NFKB1 and osteosarcoma: Importantly, tumor-derived MIF has been shown to drive NF-κB activation, proliferation, and metastasis, while pharmacologic destabilization or neutralization of MIF suppresses tumor progression and enhances responses to PD-1 blockade, supporting its translational relevance in osteosarcoma (50).